ABCG2 and cancer: It also influences drug bioavailability and toxicity, acting as a barrier in the blood-brain barrier, liver, and intestines, with alterations linked to treatment failure in cancers with high ABCG2 expression (Wang et al., 2020; Franczyk et al., 2022).